HHLA2 and cancer: To illustrate, this database shows that a high percentage of samples from patients with cancer express different ERVs, such as HER-V, HERV-K, and HERV-H LTR–associating protein 2 (HHLA-2), among others (summarized in Table 2; ref. 43).